• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma.

作者信息

Long Xiaolu, Xu Qian, Lou Yaoyao, Li Chunrui, Gu Jia, Cai Haodong, Wang Di, Xu Jinhuan, Li Tongjuan, Zhou Xiaoxi, Xiao Min, Wang Ying, Mao Xia, Zhou Jianfeng, Chen Liting

机构信息

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R.China.

出版信息

Br J Haematol. 2020 Apr;189(2):e45-e48. doi: 10.1111/bjh.16440. Epub 2020 Mar 19.

DOI:10.1111/bjh.16440
PMID:32191818
Abstract
摘要

相似文献

1
The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma.非侵入性液体活检在髓外多发性骨髓瘤的突变分析和微小残留病评估中的应用
Br J Haematol. 2020 Apr;189(2):e45-e48. doi: 10.1111/bjh.16440. Epub 2020 Mar 19.
2
Liquid Biopsies - the Clinics and the Molecules.液体活检——临床与分子
Klin Onkol. 2017 Summer;30(Supplementum2):13-20. doi: 10.14735/amko20172S13.
3
Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma.液体活检和基于血液的多发性骨髓瘤微小残留病灶评估。
Oncol Res. 2023 May 24;31(3):271-274. doi: 10.32604/or.2023.028668. eCollection 2023.
4
Liquid biopsies for multiple myeloma in a time of precision medicine.液体活检在精准医学时代的多发性骨髓瘤中的应用。
J Mol Med (Berl). 2020 Apr;98(4):513-525. doi: 10.1007/s00109-020-01897-9. Epub 2020 Apr 4.
5
Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection.侵袭性和髓外浆细胞骨髓瘤可逃避骨髓流式细胞术微小残留病检测。
Br J Haematol. 2016 Jun;173(6):947-9. doi: 10.1111/bjh.13655. Epub 2015 Oct 12.
6
Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease.全面描绘微小残留病灶中循环和骨髓衍生多发性骨髓瘤细胞的特征。
Semin Hematol. 2018 Jan;55(1):33-37. doi: 10.1053/j.seminhematol.2018.02.010. Epub 2018 Mar 1.
7
Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients.采用质谱法对外周血进行液体活检可检测多发性骨髓瘤患者的原发性髓外疾病。
Sci Rep. 2024 Aug 13;14(1):18777. doi: 10.1038/s41598-024-69408-1.
8
Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma.循环肿瘤 DNA 检测多发性骨髓瘤微小残留病。
Semin Hematol. 2018 Jan;55(1):38-40. doi: 10.1053/j.seminhematol.2018.03.002. Epub 2018 Mar 7.
9
A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation.接受自体干细胞移植的多发性骨髓瘤患者中，ASO-qPCR、微滴式数字PCR和下一代测序在自体移植物中检测微小残留病的比较。
Br J Haematol. 2018 Nov;183(4):664-668. doi: 10.1111/bjh.15002. Epub 2017 Dec 22.
10
Minimal residual disease detection of myeloma using sequencing of immunoglobulin heavy chain gene VDJ regions.使用免疫球蛋白重链基因 VDJ 区测序检测骨髓瘤微小残留病灶。
Semin Hematol. 2018 Jan;55(1):13-18. doi: 10.1053/j.seminhematol.2018.02.007. Epub 2018 Feb 23.

引用本文的文献

1
Unveiling Extramedullary Myeloma Immune Microenvironment: A Systematic Review.揭示髓外骨髓瘤免疫微环境：一项系统综述
Cancers (Basel). 2025 Mar 24;17(7):1081. doi: 10.3390/cancers17071081.
2
Extramedullary Multiple Myeloma: Challenges and Opportunities.髓外多发性骨髓瘤：挑战与机遇
Curr Oncol. 2025 Mar 20;32(3):182. doi: 10.3390/curroncol32030182.
3
Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma.解读多发性骨髓瘤中嵌合抗原受体T细胞治疗后循环肿瘤DNA的反应动态及治疗耐药性
Nat Commun. 2025 Feb 20;16(1):1824. doi: 10.1038/s41467-025-56486-6.
4
Plasma Cell Neoplasms with Spreading in the Blood and Tissues: Extramedullary Myeloma Disease, a Rare Aggressive Form of Multiple Myeloma (First of Two Parts).血液和组织中播散的浆细胞肿瘤：髓外骨髓瘤，一种罕见的侵袭性多发性骨髓瘤（两部分中的第一部分）
Mediterr J Hematol Infect Dis. 2025 Jan 1;17(1):e2025005. doi: 10.4084/MJHID.2025.005. eCollection 2025.
5
Circulating Tumor DNA Combining with Imaging Analysis for Lesion Detection of Langerhans Cell Histiocytosis in Children.循环肿瘤DNA联合影像分析用于儿童朗格汉斯细胞组织细胞增多症病灶检测
Children (Basel). 2024 Nov 27;11(12):1449. doi: 10.3390/children11121449.
6
Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma.多发性骨髓瘤中不同部位肿瘤细胞中 RAS-ERK 通路基因的杂合性丢失和突变。
Int J Mol Sci. 2024 Aug 30;25(17):9426. doi: 10.3390/ijms25179426.
7
Enhancing mutation detection in multiple myeloma with an error-corrected ultra-sensitive NGS assay without plasma cell enrichment.使用无需浆细胞富集的纠错超灵敏NGS检测法增强多发性骨髓瘤中的突变检测
Cancer Cell Int. 2024 Aug 12;24(1):282. doi: 10.1186/s12935-024-03470-7.
8
Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment.利用3D模型揭示骨髓瘤浆细胞逃离骨髓微环境的动态过程。
Cancers (Basel). 2024 Feb 22;16(5):889. doi: 10.3390/cancers16050889.
9
Genetic Abnormalities in Extramedullary Multiple Myeloma.髓外多发性骨髓瘤中的遗传异常。
Int J Mol Sci. 2023 Jul 9;24(14):11259. doi: 10.3390/ijms241411259.
10
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future.多发性骨髓瘤中的微小残留病：过去、现在与未来
Cancers (Basel). 2023 Jul 20;15(14):3687. doi: 10.3390/cancers15143687.